Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX9WTI
|
||||
| Drug Name |
[(S)-1-((R)-1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (S)-(1,2,3,4-tetrahydro-naphthalen-1-yl) ester
|
||||
| Synonyms |
CHEMBL195963
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C26H32N2O4
|
||||
| Canonical SMILES |
CCCC[C@H](NC(=O)O[C@H]1CCCc2ccccc12)C(=O)C(=O)N[C@H](C)c3ccccc3
|
||||
| InChI |
InChI=1S/C26H32N2O4/c1-3-4-16-22(24(29)25(30)27-18(2)19-11-6-5-7-12-19)28-26(31)32-23-17-10-14-20-13-8-9-15-21(20)23/h5-9,11-13,15,18,22-23H,3-4,10,14,16-17H2,1-2H3,(H,27,30)(H,28,31)/t18-,22+,23+/m1/s1
|
||||
| InChIKey |
SDWKGFZATWAOLK-LEOXJPRUSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.